Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival.

MLA

Kitagawa, Yuichiro, et al. “Serum Syndecan-1 Concentration in Hospitalized Patients with Heart Failure May Predict Readmission-Free Survival.” PloS One, vol. 16, no. 12, Dec. 2021, p. e0260350. EBSCOhost, https://doi.org/10.1371/journal.pone.0260350.

APA

Kitagawa, Y., Kawamura, I., Suzuki, K., Okada, H., Ishihara, T., Tomita, H., Suzuki, K., Takada, C., Sampei, S., Kano, S., Kondo, K., Asano, H., Wakayama, Y., Kamidani, R., Kawasaki, Y., Fukuda, H., Nishio, A., Miyake, T., Fukuta, T., … Ogura, S. (2021). Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival. PloS One, 16(12), e0260350. https://doi.org/10.1371/journal.pone.0260350

Chicago

Kitagawa, Yuichiro, Itta Kawamura, Keiko Suzuki, Hideshi Okada, Takuma Ishihara, Hiroyuki Tomita, Kodai Suzuki, et al. 2021. “Serum Syndecan-1 Concentration in Hospitalized Patients with Heart Failure May Predict Readmission-Free Survival.” PloS One 16 (12): e0260350. doi:10.1371/journal.pone.0260350.